Olanzapine 5 mg for Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma Receiving Cisplatin-Based Concurrent Chemoradiotherapy

Table 1

Characteristics of the study patients ().

Variables		%
Gender
Male	68	77.3
Female	20	22.7
Age (year)
Mean	46
Range	23-68
Smoking history
Yes	50	56.8
No	38	43.2
Alcohol consumption
Yes	22	25
No	66	75
Pathological type
Undifferentiated non-keratinizing carcinoma	76	86.4
Differentiated non-keratinizing carcinoma	9	10.2
Mixed type of above two	3	3.4
Clinical stage
II	14	15.9
III	36	40.9
IVa	33	37.5
IVb	5	5.7
T stage
T1	12	13.6
T2	20	22.7
T3	40	45.5
T4	16	18.2
N stage
N0	4	4.6
N1	33	37.5
N2	28	31.8
N3	23	26.1
M stage
M0	83	94.3
M1	5	5.7
Induction chemotherapy
Yes	62	70.5
No	26	29.5